Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation

View source ↗

Summary

A post-approval real-world study by Nyxoah Inc. is evaluating bilateral hypoglossal nerve stimulation therapy for obstructive sleep apnea and is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypoglossal nerve stimulation device

Snippet

Sponsor: Nyxoah Inc. | Conditions: Obstructive Sleep Apnea | Status: NOT_YET_RECRUITING